Basic Sciencelow evidence

IRF2BP2-FOSL2 interaction regulates SOX9-mediated cartilage regeneration in osteoarthritis models.

The Journal of clinical investigation·October 15, 2026·PMID 42878073

Why it matters

Osteoarthritis lacks effective disease-modifying therapies. This work uncovers a novel regulatory axis—IRF2BP2/FOSL2/SOX9—that controls chondrocyte phenotype and cartilage repair. Targeting this pathway with intra-articular agents may offer a new therapeutic strategy for OA and cartilage regeneration.

Infographic summary of IRF2BP2-FOSL2 interaction regulates SOX9-mediated cartilage regeneration in osteoarthritis models.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled